Fumaria Officinalis Extract

Fumaria Officinalis Extract and pregnancy

Caution Advised

• Absorbed into the body

Fumaria officinalis extract comes from a medicinal plant that contains alkaloids including protopine and sanguinarine. These compounds have been studied in herbal medicine contexts, where oral consumption during pregnancy is generally not recommended. While topical application results in lower systemic absorption compared to oral use, specific studies on topical fumaria extract during pregnancy are not available. The alkaloid content raises theoretical concerns about fetal exposure, as some plant alkaloids can cross the placental barrier. Fumitory has traditionally been used as a mild laxative and liver tonic, but its effects on pregnancy have not been adequately studied. Neither ACOG nor major obstetric guidelines specifically address topical fumaria extract. Due to the lack of safety data and the presence of bioactive alkaloids, many healthcare providers recommend avoiding botanical extracts with medicinal properties during pregnancy as a precautionary measure. Women concerned about this ingredient may choose to postpone use until after delivery.

Fumaria Officinalis Extract and breastfeeding

Caution Advised

• Passes into breast milk

Fumaria officinalis extract contains alkaloids that are fat-soluble compounds, which theoretically could pass into breast milk if absorbed systemically through the skin. The extent of dermal absorption and subsequent milk transfer has not been studied for topical cosmetic use. While topical application is expected to result in minimal systemic absorption compared to oral ingestion, no data exists to confirm the safety of fumitory extract during breastfeeding. Traditional herbal medicine sources advise against internal use during lactation due to alkaloid content. Without adequate safety data for breastfeeding mothers, dermatologists and lactation consultants typically recommend choosing well-studied ingredients over botanicals with unknown safety profiles. More research is needed to determine if topical use poses any risk to breastfed infants.

Fumaria Officinalis Extract and postpartum

Safe to Use

For postpartum women who are not breastfeeding, fumaria officinalis extract can be used with minimal concern. The botanical extract may provide anti-inflammatory benefits for skin recovering from hormonal changes. As with any botanical ingredient, patch testing is recommended to check for allergic sensitivity. The ingredient has a traditional use history in skincare, though modern cosmetic safety data remains limited.

Fumaria Officinalis Extract and trying to conceive

Safe to Use

For women trying to conceive, fumaria officinalis extract used topically in cosmetics is unlikely to impact fertility. The minimal systemic absorption from topical application makes reproductive effects improbable. While there is limited data on this specific ingredient, topical botanical extracts in cosmetic concentrations are generally considered low concern for fertility. Women who become pregnant should reassess their product use, as pregnancy recommendations differ from TTC guidance.

Fumaria Officinalis Extract and PCOS

Safe to Use

Fumaria officinalis extract does not have known hormonal activity that would impact PCOS. The plant extract is used primarily for its anti-inflammatory and soothing properties in skincare formulations. For women with PCOS who often experience inflammatory skin conditions like acne, the anti-inflammatory properties may be beneficial. There is no evidence that topical application of fumaria extract affects androgen levels or insulin sensitivity. The ingredient can be safely used as part of a skincare routine for PCOS management, though more targeted anti-acne ingredients may provide better results for hormonal breakouts.

Fumaria Officinalis Extract and general use

Safe to Use

• Common allergen

Fumaria officinalis extract is a botanical ingredient with traditional use in herbal medicine and emerging use in cosmetics for its anti-inflammatory and skin-soothing properties. The extract contains alkaloids and flavonoids that may provide antioxidant benefits. The primary concern for general users is potential for allergic contact dermatitis, as with any plant-derived ingredient. Individuals with sensitive skin or known plant allergies should patch test before widespread use. The ingredient has not been associated with significant irritation or other adverse effects in cosmetic formulations. While not extensively studied compared to more common cosmetic ingredients, fumaria extract is permitted in both EU and US cosmetics without specific restrictions. It appears safe for routine topical use in the general population, though long-term safety data is limited.

Everything else flagged for the same profiles

• Flagged in pregnancy
• Flagged in breastfeeding

Related ingredients

Ingredients suggested in place of Fumaria Officinalis Extract, each one with its own page here.

• Niacinamide
• Allantoin
• Bisabolol

Ingredients that raise the same concerns.

• PropylparabenPasses into breast milk, Common allergen, Absorbed into the body
• Lavandula Angustifolia OilPasses into breast milk, Common allergen, Absorbed into the body
• OctocrylenePasses into breast milk, Common allergen, Absorbed into the body
• Benzophenone-4Passes into breast milk, Common allergen, Absorbed into the body
• Benzophenone-3Passes into breast milk, Common allergen, Absorbed into the body
• Arnica Montana Flower ExtractPasses into breast milk, Common allergen, Absorbed into the body

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on 15 September 2026.